Medtronic PLC Cash Flow Conversion Efficiency
Medtronic PLC cash flow conversion efficiency. Based on the latest financial reports, Medtronic PLC (MDT) has a cash flow conversion efficiency ratio of 0.051x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.57 Billion) by net assets ($50.07 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medtronic PLC (1990–2026)
Cash flow conversion efficiency of Medtronic PLC from 1990 to 2026. This chart illustrates how Medtronic PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Medtronic PLC for real-time trading data and today's change.
Medtronic PLC Cash Flow Conversion Ratio Explained
Medtronic PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medtronic PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtronic PLC ranked by their cash flow conversion efficiency. Also see MDT company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DBS GROUP ADR/4 SD 1
F:DEV
|
N/A |
|
FAST RETAIL. CO. ADR 1/10
F:FR70
|
0.073x |
|
GlaxoSmithKline plc
MX:GSKN
|
0.141x |
|
GlaxoSmithKline PLC ADR
NYSE:GSK
|
0.149x |
|
Canadian Imperial Bank Of Commerce
TO:CM
|
0.246x |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
0.217x |
|
Accenture plc
NYSE:ACN
|
0.115x |
|
ServiceNow Inc
NYSE:NOW
|
0.173x |
Annual Cash Flow Conversion Efficiency for Medtronic PLC (1990–2026)
The table below shows the annual cash flow conversion efficiency of Medtronic PLC from 1990 to 2026. Review MDT free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-04-30 | $50.07 Billion | $7.33 Billion | 0.146x | +0.29% |
| 2025-04-30 | $48.26 Billion | $7.04 Billion | 0.146x | +8.44% |
| 2024-04-30 | $50.42 Billion | $6.79 Billion | 0.135x | +15.16% |
| 2023-04-30 | $51.66 Billion | $6.04 Billion | 0.117x | -16.11% |
| 2022-04-30 | $52.72 Billion | $7.35 Billion | 0.139x | +15.22% |
| 2021-04-30 | $51.60 Billion | $6.24 Billion | 0.121x | -14.96% |
| 2020-04-30 | $50.87 Billion | $7.23 Billion | 0.142x | +1.90% |
| 2019-04-30 | $50.21 Billion | $7.01 Billion | 0.140x | +51.41% |
| 2018-04-30 | $50.82 Billion | $4.68 Billion | 0.092x | -32.46% |
| 2017-04-30 | $50.42 Billion | $6.88 Billion | 0.136x | +35.54% |
| 2016-04-30 | $51.83 Billion | $5.22 Billion | 0.101x | +9.33% |
| 2015-04-30 | $53.23 Billion | $4.90 Billion | 0.092x | -63.89% |
| 2014-04-30 | $19.44 Billion | $4.96 Billion | 0.255x | -2.48% |
| 2013-04-30 | $18.67 Billion | $4.88 Billion | 0.262x | +0.12% |
| 2012-04-30 | $17.11 Billion | $4.47 Billion | 0.261x | +11.49% |
| 2011-04-30 | $15.97 Billion | $3.74 Billion | 0.234x | -17.03% |
| 2010-04-30 | $14.63 Billion | $4.13 Billion | 0.282x | -6.42% |
| 2009-04-30 | $12.85 Billion | $3.88 Billion | 0.302x | -0.22% |
| 2008-04-30 | $11.54 Billion | $3.49 Billion | 0.302x | +11.44% |
| 2007-04-30 | $10.98 Billion | $2.98 Billion | 0.271x | +15.35% |
| 2006-04-30 | $9.38 Billion | $2.21 Billion | 0.235x | -12.80% |
| 2005-04-30 | $10.45 Billion | $2.82 Billion | 0.270x | -13.94% |
| 2004-04-30 | $9.08 Billion | $2.85 Billion | 0.314x | +19.28% |
| 2003-04-30 | $7.91 Billion | $2.08 Billion | 0.263x | +6.30% |
| 2002-04-30 | $6.43 Billion | $1.59 Billion | 0.247x | -25.62% |
| 2001-04-30 | $5.51 Billion | $1.83 Billion | 0.332x | +43.29% |
| 2000-04-30 | $4.49 Billion | $1.04 Billion | 0.232x | +86.22% |
| 1999-04-30 | $3.65 Billion | $455.30 Million | 0.125x | -63.26% |
| 1998-04-30 | $2.04 Billion | $693.10 Million | 0.339x | +27.71% |
| 1997-04-30 | $1.75 Billion | $463.60 Million | 0.265x | -5.09% |
| 1996-04-30 | $1.79 Billion | $500.50 Million | 0.280x | -3.56% |
| 1995-04-30 | $1.33 Billion | $387.20 Million | 0.290x | -14.39% |
| 1994-04-30 | $1.05 Billion | $356.90 Million | 0.339x | -2.20% |
| 1993-04-30 | $841.50 Million | $291.50 Million | 0.346x | +82.24% |
| 1992-04-30 | $796.50 Million | $151.40 Million | 0.190x | +2.58% |
| 1991-04-30 | $683.20 Million | $126.60 Million | 0.185x | -6.13% |
| 1990-04-30 | $541.00 Million | $106.80 Million | 0.197x | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardiovert… Read more